Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The EN-TEx resource of multi-tissue personal epigenomes & variant-impact models. | Cell | 2023 | 37001506 | PubTator, text mining | PubMed |
| Cross-phenotype association analysis of gastric cancer: in-silico functional annotation based on the disease-gene network. | Gastric Cancer | 2023 | 36995485 | PubTator, text mining | PubMed |
| Antibody-Biopolymer Conjugates in Oncology: A Review. | Molecules | 2023 | 36985578 | PubTator, text mining | PubMed |
| An 8q24 Gain in Pancreatic Juice Is a Candidate Biomarker for the Detection of Pancreatic Cancer. | Int J Mol Sci | 2023 | 36982172 | PubTator, text mining | PubMed |
| The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches. | Biomedicines | 2023 | 36979805 | PubTator, text mining | PubMed |
| State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer. | Front Oncol | 2023 | 36969009 | PubTator, text mining | PubMed |
| Identification of lncRNA and mRNA regulatory networks associated with gastric cancer progression. | Front Oncol | 2023 | 36969001 | PubTator, text mining | PubMed |
| Prostate cancer bone metastases biology and clinical management (Review). | Oncol Lett | 2023 | 36960185 | PubTator, text mining | PubMed |
| Combining chemotherapy with CAR-T cell therapy in treating solid tumors. | Front Immunol | 2023 | 36949946 | PubTator, text mining | PubMed |
First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC). | J Immunother Cancer | 2023 | 36948505 | PubTator, text mining | PubMed |
| Progression in immunotherapy for advanced prostate cancer. | Front Oncol | 2023 | 36925917 | PubTator, text mining | PubMed |
| Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. | J Transl Med | 2023 | 36922828 | PubTator, text mining | PubMed |
| Research progress on non-protein-targeted drugs for cancer therapy. | J Exp Clin Cancer Res | 2023 | 36918935 | PubTator, text mining | PubMed |
| Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy. | Clin Cancer Res | 2023 | 36917693 | PubTator, text mining | PubMed |
| Transcriptomic profiling and differential analysis reveal the renal toxicity mechanisms of mice under cantharidin exposure. | Toxicol Appl Pharmacol | 2023 | 36907384 | PubTator, text mining | PubMed |
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer. | Cancers (Basel) | 2023 | 36900394 | PubTator, text mining | PubMed |
| Liquid Biopsies, Novel Approaches and Future Directions. | Cancers (Basel) | 2023 | 36900369 | PubTator, text mining | PubMed |
| Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer. | Cancers (Basel) | 2023 | 36900202 | PubTator, text mining | PubMed |
| Current applications of nanomaterials in urinary system tumors. | Front Bioeng Biotechnol | 2023 | 36890910 | PubTator, text mining | PubMed |
| Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis. | Brain | 2023 | 36883643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=11